Skip to content

HORIZONH2020FP7

Syreon Kutato Intezet Korlatolt Felelossegu Tarsasag

Country
HUHungary
Defence projects
0
Projects, all programmes
16
As coordinator
0
EU contribution (CORDIS)
EUR 6,180,099
Active
2013 to 2024

Projects

16 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
SUSTAIN-HTASupport Utilisation of Sustainable and TAilored INnovative methods for HTAHORIZON2024ParticipantEUR 350,656
CATALYSECatalysing scientific innovation into food safety actionHORIZON2024ParticipantEUR 98,900
Invest4HealthMobilising novel finance models for health promotion and disease preventionHORIZON2023ParticipantEUR 304,813
IMMUTOLADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASESHORIZON2023ParticipantEUR 306,250
TRUSTINGA TRUSTworthy speech-based AI monitorING system for the prediction of relapse in individuals with schizophreniaHORIZON2023ParticipantEUR 292,250
DE-ESCALATEINTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIALHORIZON2023ParticipantEUR 518,750
LEGATOLomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III studyHORIZON2023ParticipantEUR 518,750
STREXIT2A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMAHORIZON2023ParticipantEUR 518,750
REMEDi4ALLBUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALLHORIZON2022ParticipantEUR 791,813
HEcoPerMedHealthcare- and pharma-economic models in support of the International Consortium for Personalised MedicineH20202019ParticipantEUR 289,610
VITALVaccines and Infectious Diseases in the Ageing PopuLationH20202019ParticipantEUR 255,976
HTxNext Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout EuropeH20202019ParticipantEUR 679,163
COMEDPushing the boundaries of Cost and Outcome analysis of Medical TechnologiesH20202018ParticipantEUR 331,000
EU-TOPIAEU-TOPIA: TOWARDS IMPROVED SCREENING FOR BREAST, CERVICAL AND COLORECTAL CANCER IN ALL OF EUROPEH20202015ParticipantEUR 253,250
SELFIESustainable intEgrated care modeLs for multi-morbidity: delivery, FInancing and performancEH20202015ParticipantEUR 429,238
EQUIPTEuropean-study on Quantifying Utility of Investment in Protection from TobaccoFP72013ParticipantEUR 240,931

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.